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igital PCR, a technique for the future
We  are very pleased to be able to bring you this special issue of
iomolecular Detection and Quantiﬁcation which focuses on digital
CR (dPCR). The underpinning method of dPCR, which was  coined
n 1999 [1], actually predates qPCR [2] and is a powerful technique
hat could offer improved sensitivity, precision and reproducibility
3]. Now is an exciting time for this method and there are numerous
xamples of where the improved reproducibility can be applied
linically and where the superior sensitivity and precision could
nable measurements to be performed that are simply not possible
sing PCR or, in many cases, sequencing.
In this special issue we have selected seven manuscripts that
iscuss and present dPCR in a variety of subjects. Dhillon et al.
resent a new application of dPCR in the form of a proximity liga-
ion assay (PLA) opening the possibility of using limiting dilution to
mprove the detection and quantiﬁcation of proteins which, in this
ase focussed on Clostridium difﬁcile toxins, are important markers
or disease. Matthew Butchbach presents a review on the appli-
ation of dPCR as a robust method to identify genes associated
ith paediatric-onset disorders. This review also highlights how
PCR can offer a powerful technology to track changes in genomic
iomarkers with disease progression. He also argues that dPCR has
he potential to become the tool of choice for the veriﬁcation of
utations identiﬁed by next generation sequencing, copy number
etermination and also for non-invasive prenatal screening.
The next four manuscripts deal with the application and analysis
PCR. Whale et al. discuss multiplexing by dPCR and describe the
ifferent approaches that can be applied highlighting the unique
pproaches on offer by dPCR. They also report and name a charac-
eristic of dPCR, namely partition speciﬁc competition (PSC), that
ust be considered when applying thresholds to multiplex assays
hat use the same primers but different probes, as is common when
easuring single nucleotide variants or polymorphisms. Debski
nd Garstecki describe how to design dPCR experiments to ensure
esired precision is achieved when dealing with patient samples.
his is an important and frequently neglected consideration when
iscussing the performance of any molecular method. Jones and
olleagues present a short report that investigates the dynamic
ange of dPCR, which is often reported as being at a disadvantage
hen compared with qPCR. In this study they demonstrate that if
ou have enough partitions it is possible to perform dPCR with a
ynamic range of up to six orders of magnitude, which is approach-
ng that of qPCR. Finally the manuscript by Madic et al. describes
pplication of the ﬁrst three colour dPCR instrument for multiplex
nalysis of three mutations of the EGFR gene. This droplet-based
latform applies a unique sample partition format by employing a
ttp://dx.doi.org/10.1016/j.bdq.2016.10.003
214-7535/© 2016 Published by Elsevier GmbH. This is an open access article under the C“2D droplet array” that can be directly imaged following the PCR
reaction.
The last article deals with accuracy, reliability and reproducibil-
ity in the context of nucleic acid quantiﬁcation and highlights how
dPCR could be used to quantify reference materials. Bhat and Emslie
also discuss how the use of reference materials and certiﬁed ref-
erence materials, already established when measuring many bio-
chemical analytes, could support the traceable analysis of molecu-
lar targets such as BCR-ABL1 [4]. While dPCR is already being used
to quantify such materials, they highlight the fact that further work
is required to better understand sources of bias and uncertainty.
We hope you enjoy these articles which illustrate the potential
of this fairly new and unique molecular method. We  are of the opin-
ion that dPCR offers considerable potential as a method that will
advance clinical research and routine diagnosis and could become
the method of choice in areas such as precision and personalised
healthcare. This special issue will add to the increasing body of lit-
erature reporting on the use of digital PCR in every day laboratory
practises and offer solutions to some of remaining challenges and
pitfalls that could be encountered.
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